Advancements in new hepatitis C treatments

June 3, 2016

Hepatitis C is the leading blood-borne disease in the U.S., with more than 3.5 million people developing a chronic infection. While the outlook for treating hepatitis C was grim just a few years ago, now most patients can be cured with direct-acting antiviral medications, many of them evaluated at the UT Health Science Center San Antonio.